Search
Amgen Worldwide Web Resources
×

Do you want to link to this External Site and leave Amgen.com?

No, Return to Amgen.com Yes, Leave Amgen.com

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Press Releases

INVESTORS

Press Releases

RSS

12/04/20

Amgen and McKesson Launch Strategic Agreement to Advance Cancer Innovation in Communities

12/03/20

Amgen To Webcast Investor Call At ASH 2020

11/30/20

World's Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19

11/30/20

Amgen Announces New Data Being Presented At ASH 2020

11/25/20

Amgen To Present At The Evercore ISI Virtual HealthCONx Conference

11/23/20

Amgen To Transition Development And Commercial Rights For Omecamtiv Mecarbil And AMG 594 To Cytokinetics

11/13/20

Amgen To Present At The Jefferies Virtual London Healthcare Conference

11/10/20

Amgen To Present At The Cowen 4th Annual IO Summit

11/10/20

Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma

11/09/20

Amgen Showcases New Data Across Cardiovascular Portfolio At AHA Scientific Sessions 2020: A Virtual Experience

11/09/20

Amgen Presents First Clinical Data for AMG 757 at SITC 2020

11/04/20

Amgen To Present At The 29th Annual Credit Suisse Healthcare Conference

10/28/20

Amgen Reports Third Quarter 2020 Financial Results

10/27/20

Amgen Announces Webcast Of 2020 Third Quarter Financial Results

10/27/20

Amgen Announces Participation Of Systemic Lupus Erythematosus (SLE) Adaptive Clinical Trial In The FDA Complex Innovative Trial Designs (CID) Pilot Program

10/26/20

Global Coalition for Adaptive Research, Amgen, and Eisai Announce First Patient Enrolled in International COVID-19 Trial

10/21/20

Amgen Announces 2020 Fourth Quarter Dividend

10/08/20

Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

10/05/20

Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer

10/03/20

Amgen Announces Five-Year Data That Reinforce The Safety And Efficacy Profile Of Aimovig® (erenumab-aooe) In Adult Patients With Episodic Migraine

09/20/20

Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine

09/17/20

Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies

09/16/20

Amgen To Webcast Investor Calls At ESMO 2020

09/16/20

Amgen To Showcase Data From Oncology Pipeline During ESMO Virtual Congress 2020

09/15/20

Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket

09/14/20

Amgen To Present At The 2020 Bank of America Virtual Global Healthcare Conference

09/11/20

Amgen To Present At The 18th Annual Morgan Stanley Global Healthcare Conference

09/04/20

Amgen To Present At The 15th Annual Citi BioPharma Conference

08/29/20

Amgen Announces Positive Data From Phase 3B Study Of Repatha® (Evolocumab) In Pediatric Patients With Heterozygous Familial Hypercholesterolemia At ESC Congress 2020

08/25/20

New Amgen Data To Be Presented At ESC Congress 2020 Highlighting Repatha® (evolocumab) Efficacy In High-Risk Patient Populations

08/20/20

FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX® (daratumumab) And Dexamethasone In Both Once- And Twice-Weekly Dosing Regimens

08/20/20

Amgen Foundation Commits $100,000 To Beirut Relief Efforts Following Explosions

08/13/20

Amgen Announces Pricing Terms For Senior Notes Exchange Offers, Increases The Maximum Notes Exchange Cap And Accepts Tendered Notes

08/13/20

Amgen Announces Early Tender Results Of Senior Notes Exchange Offers

08/03/20

Members of the COVID R&D Alliance and Quantum Leap Healthcare Collaborative Enroll First Patients in I-SPY COVID Trial

07/30/20

Amgen Commences Exchange Offers For Certain Series Of Outstanding Senior Notes From Exchange Eligible Holders

07/28/20

Amgen Reports Second Quarter 2020 Financial Results

07/23/20

Amgen Announces Webcast Of 2020 Second Quarter Financial Results

07/23/20

Amgen Announces 2020 Third Quarter Dividend

07/23/20

Amgen Appoints Amy E. Miles To Board Of Directors

07/21/20

Amgen Foundation Awards Khan Academy An Additional $3 Million To Support Science Learning And Educational Equity Amid COVID-19

07/12/20

Amgen Announces Additional Investment In BeiGene

07/01/20

Appeals Court Affirms Validity Of Enbrel® (etanercept) Patents Injunction Against Sandoz's Infringement Stands

06/22/20

Amgen Is Supporting Advancement Of AMG 634 For Global Health Diseases In Developing Countries

06/18/20

Amgen To Present At The BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference

06/16/20

New Capture the Fracture® Partnership Aims for 25% Reduction in the Incidence of Hip and Vertebral Fractures Due to Osteoporosis by 2025

06/05/20

Amgen To Present At The Goldman Sachs 41st Annual Global Healthcare Conference

05/29/20

Amgen Presents New AMG 510 Clinical Data Across Multiple Solid Tumors During ASCO20 Virtual Scientific Program

05/28/20

Amgen To Present At The Jefferies 2020 Virtual Healthcare Conference

05/26/20

Amgen To Webcast Investor Meeting At 56th Annual Meeting Of The American Society Of Clinical Oncology (ASCO)

05/20/20

Amgen Announces Voting Results Of Annual Meeting Of Stockholders

05/13/20

Amgen Showcases Oncology Pipeline At ASCO 2020

05/12/20

Amgen To Present At The Bank Of America Merrill Lynch Virtual Global Healthcare Conference

05/08/20

FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure

05/06/20

Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 ADVANCE Study In Mild-To-Moderate Plaque Psoriasis

05/05/20

KYPROLIS® (carfilzomib) Patents Upheld Against Generic Manufacturer

05/04/20

Amgen To Present At The SunTrust Robinson Humphrey Life Sciences Summit Virtual Meeting Series

04/30/20

Amgen Reports First Quarter 2020 Financial Results

04/27/20

Amgen Announces Webcast Of 2020 First Quarter Financial Results

04/14/20

Iceland Provides a Picture of the Early Spread of COVID-19 in a Population with a Cohesive Public Health Response

04/07/20

Amgen And Adaptive Biotechnologies To Participate In Webinar On COVID-19 Strategic Collaboration

04/02/20

Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19

03/31/20

Amgen Establishes Wholly-Owned Affiliate In Japan

03/28/20

Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol

03/23/20

Amgen And The Amgen Foundation Commit Up To $12.5 Million To Support COVID-19 Relief Efforts

03/04/20

Amgen Announces 2020 Second Quarter Dividend

02/27/20

Amgen To Present At The Cowen 40th Annual Healthcare Conference

02/26/20

Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis

01/30/20

Amgen Reports Fourth Quarter And Full Year 2019 Financial Results

01/27/20

Amgen Announces Webcast Of 2019 Fourth Quarter And Full Year Financial Results

01/22/20

Free "LabXchange" Science Education Accelerator Launched By Amgen Foundation And Harvard's Faculty Of Arts And Sciences

01/13/20

Amgen Announces Global Diagnostic Collaborations To Expand Molecular Testing For Patients With Non-Small Cell Lung Cancer

01/09/20

Amgen To Present At The 38th Annual J.P. Morgan Healthcare Conference

01/07/20

Amgen To Present At The Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference

01/02/20

Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China